Aemetis Vs. Sarepta Therapeutics Industry Stock Comparison

Sell

50

AMTX
Aemetis

Last Price:

$2.01

Seasonality Move:

15.32%

Sell

48

SRPT
Sarepta Therapeutics

Last Price:

$74.08

Seasonality Move:

14.66%

Sell

50

Aemetis (AMTX) is a Sell

Is Aemetis a Buy, Sell or Hold?

The current Aemetis [AMTX] share price is $2.01. The Score for AMTX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
AMTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

48

Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

The current Sarepta Therapeutics [SRPT] share price is $74.10. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AMTX Stock Price Chart

What is Aemetis's stock price today?

The Aemetis share price today is $2.01

The current trend is relatively stagnant and AMTX is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

The Sarepta Therapeutics share price today is $74.10

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

AMTX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.05	Sell
Relative Strength Index (14 RSI):	54.09	Buy
Chaikin Money Flow:	217936	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.72 - 2.02)	Buy
Bollinger Bands (100):	(1.98 - 3.44)	Sell

SRPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-8.7	Sell
Relative Strength Index (14 RSI):	27.9	Sell
Chaikin Money Flow:	-367389	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(88.59 - 111.17)	Sell
Bollinger Bands (100):	(103.29 - 127.87)	Sell

AMTX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.88	Buy
20-day SMA:	1.83	Buy
50-day SMA:	2.15	Sell
200-day SMA:	2.78	Sell
8-day EMA:	1.92	Buy
20-day EMA:	1.9	Buy
50-day EMA:	2.14	Sell
200-day EMA:	2.84	Sell

SRPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	87.22	Sell
20-day SMA:	97.87	Sell
50-day SMA:	108.64	Sell
200-day SMA:	125.16	Sell
8-day EMA:	84.58	Sell
20-day EMA:	94.74	Sell
50-day EMA:	105.16	Sell
200-day EMA:	118.38	Sell

Aemetis Earnings Growth & AMTX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.16 per share, an increase this year of $0.71 per share, and an increase next year of $1.15 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Aemetis Technical Analysis

	Mar 7	Mar 11	Mar 12	Mar 13	Mar 14	Mar 17	Mar 18	Mar 19	Mar 20	Mar 21
	Mar
	07	11	12	13	14	17	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

	Mar 7	Mar 11	Mar 12	Mar 13	Mar 14	Mar 17	Mar 18	Mar 19	Mar 20	Mar 21
	Mar
	07	11	12	13	14	17	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):